The molecular biologist Frank Bradke, group leader at the DZNE and professor for neurobiology at the University of Bonn, will be awarded the “Gottfried Wilhelm Leibniz Prize”, which is endowed with…
This morning, Saxony-Anhalt’s Minister of Science Hartmut Möllring inaugurated the new MR-PET device at the German Center for Neurodegenerative Diseases, site Magdeburg. The MR-PET device has opened…
Specific forms of epilepsy may manifest as early as in the first weeks of life. A new laboratory study shows that a preventive therapeutic strategy can be successful if it is applied within a time…
The neurologist Michela Deleidi was successful in her application for a “Helmholtz Young Investigators Group”, after going through a competitive selection procedure. She will receive approximately…
Universities, research institutions, scientific organizations and regional authorities in the Science Region of Bonn have now all joined the current debate on xenophobia in Germany with a common…
In cooperation with colleagues in Munich and Göttingen, researchers at the DZNE in Bonn have analyzed a novel substance that could serve as a prototype for the development of drugs to treat…
DZNE neuroepidemiologist honored for her research on dementia. The election recognizes her outstanding academic work and international scientific leadership.
Bonn/Amsterdam, September 30th, 2015 –…
Researchers in Göttingen have identified a cancer drug as a prototype drug that may be used to treat Alzheimer’s disease. This substance, known as “Vorinostat”, was found to alleviate learning and…
A team led by Christian Haass has identified a novel peptide that plays a role in Alzheimer’s disease: The previously overlooked eta-amyloid interferes with neuronal function and may antogonize…
The polar bear suffered from an autoimmune disease of the brain. This non-infectious illness is called “anti-NMDA receptor encephalitis”, with symptoms in human patients similar to those displayed by…
